1. Kilcoyne M, Shashkov AS, Senchencova SA, Knirel YA, Vinogradov EV, Radziejewska-Lebrecht J, Galimska-Stypa R, Savage AV. Structural investigation of the O-specific polysaccharides of Morganella morganii consisting of two higher sugars. Carbohydr Res. 2002. 337:1697–1702.
Article
2. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences and new directions for its management. Cancer. 2004. 100:228–237.
3. Becker RC, Giuliani M, Savage RA, Weick JK. Massive hemolysis in Clostridium perfringens infections. J Surg Oncol. 1987. 35:13–18.
4. Yamanaka H, Satoh T, Katsu T, Shinoda S. Mechanism of haemolysis by Vibrio vulnificus haemolysin. J Gen Microbiol. 1987. 133:2859–2864.
Article
5. Vento S, Cainelli F. Infection in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol. 2003. 4:595–604.
6. McDermott C, Mylotte JM. Morganella morganii: epidemiology of bacteremic disease. Infect Control. 1984. 5:131–137.
Article
7. Salen PN, Eppes S. Morganella morganii: a newly reported, rare cause of neonatal sepsis. Acad Emerg Med. 1997. 4:711–714.
Article
8. Lee IK, Liu JW. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia. J Microbiol Immunol Infect. 2006. 39:328–334.
9. Gutierrez A, Florencio R, Ezpeleta C, Cisterna R, Martinez M. Fatal intravascular hemolysis in a patient with Clostridium perfringens septicemia. Clin Infect Dis. 1995. 20:1064–1065.
Article
10. Arnaout MK, Tamburro RF, Bodner SM, Sandlund JT, Rivera GK, Pui CH, Ribeiro RC. Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemia. J Ped Hematol Oncol. 1999. 21:431–435.
Article
11. Eberspacher B, Hugo F, Pohl M, Bhakdi S. Functional similarity between the haemolysins of Escherichia coli and Morganella morganii. Med Microbiol. 1990. 33:165–170.
Article